Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence | MicrobiomeTrials← Back to trialsNCT05266807
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2023-03-15Est. Completion: 2027-04-01
Enrollment target: 100 participants Locations- Universitätsspital, Basel, Basel, Switzerland
- Inselspital Bern, Bern, Canton of Bern, Switzerland
- HFR Fribourg - Hôpital cantonal, Fribourg, Canton of Fribourg, Switzerland
- Hirslanden Klinik St Anna, Lucerne, Canton of Lucerne, Switzerland
- Kantonsspital St Gallen, HOCH, Sankt Gallen, Canton of St. Gallen, Switzerland
- CHUV, Lausanne, Canton of Vaud, Switzerland
- Universitätsspital Zürich, Zurich, Canton of Zurich, Switzerland
- Institut central des hôpitaux, Sion, Valais, Switzerland
Other microbiome trials you might be interested in
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative SyndromeHodgkin LymphomaLymphoma, Non-HodgkinMyelomaChronic Lymphocytic Leukemia
The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic h…
Amiens, FranceEst. completion May 2030
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027
DysbiosisClostridium DifficilePet-Human BondingAntibiotic-Associated Colitis
Antimicrobial therapy can lead to disruption of the gut microbiome and infection with Clostridioides difficile, a diseas…
Philadelphia, United StatesEst. completion Sep 1, 2026